α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94 cells

Osteoarthritis and Cartilage

Volumn 16, Issue 1, 2008, Pages 115-124

  Yoon, S W ^a   Chun, J S ^c   Sung, M H ^d   Kim, J Y ^b   Poo, H ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

^d Kookmin University   (South Korea)

Author keywords

MSH; HTB 94 cell; IKK; MMP 13; NF B; p38 MAP kinase; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA INTERMEDIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; I KAPPA B; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SN 50; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHONDROSARCOMA; COLLAGEN DEGRADATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALPHA-MSH; BLOTTING, WESTERN; CELL COMMUNICATION; CELL LINE, TUMOR; CHONDROSARCOMA; FEMALE; HORMONES; HUMANS; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38349161595     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.05.026     Document Type: Article

References (42)

1. Rajora N., Boccoli G., Burns D., Sharma S., Catania A.P., and Lipton J.M. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J Neurosci 17 (1997) 2181-2186
2. Lipton J.M., Zhao H., Ichiyama T., Barsh G.S., and Catania A. Mechanisms of anti-inflammatory action of alpha-MSH peptides: in vivo and in vitro evidence. Ann N Y Acad Sci 885 (1999) 173-182
3. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappaB activation induced by various inflammatory agents. J Immunol 161 (1998) 2873-2880
4. Catania A., Gerloni V., Procaccia S., Airaghi L., Manfredi M.G., Lomater C., et al. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1 (1994) 321-328
5. Luger T.A., Brzoska T., Scholzen T.E., Kalden D.H., Sunderkotter C., Armstrong C., et al. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917 (2000) 232-238
6. Ichiyama T., Zhao H., Catania A., Furukawa S., and Lipton J.M. α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157 (1999) 359-365
7. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268 (1993) 8246-8250
8. Taherzadeh S., Sharma S., Chhajlani V., Gantz I., Rajora N., Demitri M.T., et al. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 276 (1999) R1289-R1294
9. Getting S.J., Gibbs L., Clark A.J., Flower R.J., and Perretti M. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162 (1999) 7446-7453
10. Ceriani G., Diaz J., Murphree S., Catania A., and Lipton J.M. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1 (1994) 28-32
11. Elliott S., Hays E., Mayor M., Sporn M., and Vincenti M. The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes. Arthritis Res Ther 5 (2003) R285-R291
12. Migita K., Miyashita T., Ishibashi H., Maeda Y., Nakamura M., Yatsuhashi H., et al. Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts. Clin Exp Immunol 137 (2004) 612-616
13. Stadheim T.A., Suh N., Ganju N., Sporn M.B., and Eastman A. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. J Biol Chem 277 (2002) 16448-16455
14. Islam S., Kermode T., Sultana D., Moskowitz R.W., Mukhtar H., Malemud C.J., et al. Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage 9 (2001) 684-693
15. Mengshol J.A., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases as therapeutic targets in arthritic diseases. Arthritis Rheum 46 (2002) 13-20
16. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 6 (1998) 374-376
17. Knauper V., Lopez-Otin C., Smith B., Knight G., and Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 271 (1996) 1544-1550
18. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., and Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43 (2000) 801-811
19. Rifas L., and Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 48 (2003) 993-1001
20. Ling H., and Recklies A.D. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumor necrosis factor-alpha. Biochem J 15 (2004) 651-659
21. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., and Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 97 (1996) 2011-2019
22. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97 (1996) 761-768
23. Vincenti M.P., and Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4 (2002) 157-164
24. Mix K.S., Mengshol J.A., Benbow U., Vincenti M.P., Sporn M.B., and Brinckerhoff C.E. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum 44 (2001) 1096-1104
25. Leeman M.F., Curran S., and Murray G.I. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37 (2002) 149-166
26. Van Wart H.E., and Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87 (1990) 5578-5582
27. Liacini A., Sylvester J., Li W.Q., Huang W., Dehnade F., Ahmad M., et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288 1 (2003) 208-217
28. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 16 (2004) 616-622
29. Malemud C.J. Protein kinases in chondrocyte signaling and osteoarthritis. Clin Orthop 427 (2004) S145-S151
30. Ahmed S., Rahman A., Hasnain A., Goldberg V.M., and Haqqi T.M. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1. J Pharmacol Exp Ther 305 (2003) 981-988
31. Yosimichi G., Nakanishi T., Nishida T., Hattori T., Takano-Yamamoto T., and Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38 MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268 (2001) 6058-6065
32. Yoon S.W., Goh S.H., Chun J.S., Cho E.W., Lee M.K., Kim K.L., et al. Alpha-melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 278 (2003) 32914-32920
33. Yuan G.H., Tanaka M., Masuko-Hongo K., Shibakawa A., Kato T., Nishioka K., et al. Characterization of cells from pannus-like tissue over articular cartilage of advanced osteoarthritis. Osteoarthritis Cartilage 12 (2004) 38-45
34. Konttinen Y.T., Ainola M., Valleala H., Ma J., Ida H., Mandelin J., et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58 (1999) 691-697
35. Kim S.J., Hwang S.G., Shin D.Y., Kang S.S., and Chun J.S. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF kappa B-dependent transcription and stabilization by serine 15 phosphorylation. J Biol Chem 277 (2002) 33501-33508
36. Getting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111 (2006) 1-15
37. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 3 (2002) 221-227
38. Louis E., Ribbens C., Godon A., Franchimont D., De Groote D., Hardy N., et al. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 120 2 (2000) 241-246
39. McMillan S.J., Kearley J., Campbell J.D., Zhu X.W., Larbi K.Y., Shipley J.M., et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 172 4 (2004) 2586-2594
40. Im H.J., Pacione C., Chubinskaya S., Van Wijnen A.J., Sun Y., and Loeser R.F. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1β-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 278 (2003) 25386-25394
41. Ohno S., Im H.J., Knudson C.B., and Knudson W. Hyaluronan oligosaccharides induce MMP-13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem 281 (2006) 17952-17960
42. Pattoli M.A., MacMaster J.F., Gregor K.R., and Burke J.R. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression. J Pharmacol Exp Ther 315 (2005) 382-388